US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist
  • 4.2664
  • +0.0128+0.30%
Close May 29 16:00 ET
3.56MMarket Cap-32P/E (TTM)

About ZyVersa Therapeutics Company

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.

Company Profile

SymbolZVSA
Company NameZyVersa Therapeutics
Listing DateFeb 10, 2022
Founded2014
CEOMr. Stephen C. Glover
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends01-01
Address2200 North Commerce Parkway,Suite 208
CityWeston
ProvinceFlorida
CountryUnited States of America
Zip Code33326
Phone1-754-231-1688

Company Executives

  • Name
  • Position
  • Salary
  • Stephen C. Glover
  • Chairman of the Board, Chief Executive Officer and President
  • 1.48M
  • Peter Wolfe
  • Chief Financial Officer, Secretary and Principal Accounting Officer
  • --
  • Pablo A. Guzman, M.D.
  • Chief Medical Officer and Senior Vice President, Medical Affairs
  • --
  • Karen A. Cashmere
  • Chief Commercial Officer
  • 582.62K
  • Robert G. Finizio
  • Director
  • 165.47K
  • Gregory G. Freitag, C.P.A.,J.D.
  • Director
  • --
  • Dr. Min-Chul Park, Pd.D
  • Director
  • 158.47K
  • James Sapirstein
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg